Glenmede Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $2.3M | Sell |
4,735
-90
| -2% | -$43.6K | 0.01% | 530 |
|
2024
Q4 | $1.94M | Buy |
4,825
+732
| +18% | +$295K | 0.01% | 556 |
|
2024
Q3 | $1.9M | Sell |
4,093
-128,725
| -97% | -$59.9M | 0.01% | 571 |
|
2024
Q2 | $62.3M | Sell |
132,818
-2,263
| -2% | -$1.06M | 0.32% | 77 |
|
2024
Q1 | $56.5M | Sell |
135,081
-39,015
| -22% | -$16.3M | 0.28% | 85 |
|
2023
Q4 | $70.8M | Sell |
174,096
-20,297
| -10% | -$8.26M | 0.37% | 67 |
|
2023
Q3 | $67.6M | Sell |
194,393
-4,348
| -2% | -$1.51M | 0.39% | 63 |
|
2023
Q2 | $62.6M | Sell |
198,741
-106
| -0.1% | -$33.4K | 0.36% | 77 |
|
2023
Q1 | $62.7M | Buy |
198,847
+8,144
| +4% | +$2.57M | 0.36% | 77 |
|
2022
Q4 | $55.1M | Buy |
190,703
+30,980
| +19% | +$8.95M | 0.32% | 82 |
|
2022
Q3 | $46.2M | Buy |
159,723
+2,151
| +1% | +$623K | 0.29% | 94 |
|
2022
Q2 | $44.4M | Sell |
157,572
-3,403
| -2% | -$959K | 0.26% | 97 |
|
2022
Q1 | $42M | Buy |
160,975
+147,028
| +1,054% | +$38.4M | 0.21% | 118 |
|
2021
Q4 | $3.06M | Sell |
13,947
-1,345
| -9% | -$295K | 0.01% | 490 |
|
2021
Q3 | $2.77M | Buy |
15,292
+2,493
| +19% | +$452K | 0.01% | 485 |
|
2021
Q2 | $2.58M | Buy |
12,799
+6,295
| +97% | +$1.27M | 0.01% | 488 |
|
2021
Q1 | $1.4M | Sell |
6,504
-59,113
| -90% | -$12.7M | 0.01% | 607 |
|
2020
Q4 | $15.5M | Buy |
65,617
+61,958
| +1,693% | +$14.6M | 0.09% | 263 |
|
2020
Q3 | $994K | Buy |
3,659
+550
| +18% | +$149K | 0.01% | 620 |
|
2020
Q2 | $901K | Buy |
3,109
+594
| +24% | +$172K | 0.01% | 632 |
|
2020
Q1 | $550K | Hold |
2,515
| – | – | ﹤0.01% | 875 |
|
2019
Q4 | $550K | Sell |
2,515
-94
| -4% | -$20.6K | ﹤0.01% | 875 |
|
2019
Q3 | $441 | Buy |
2,609
+292
| +13% | +$49 | ﹤0.01% | 926 |
|
2019
Q2 | $424 | Buy |
2,317
+409
| +21% | +$75 | ﹤0.01% | 947 |
|
2019
Q1 | $350 | Sell |
1,908
-276
| -13% | -$51 | ﹤0.01% | 993 |
|
2018
Q4 | $361 | Buy |
2,184
+444
| +26% | +$73 | ﹤0.01% | 933 |
|
2018
Q3 | $334K | Buy |
1,740
+46
| +3% | +$8.83K | ﹤0.01% | 991 |
|
2018
Q2 | $288K | Sell |
1,694
-87
| -5% | -$14.8K | ﹤0.01% | 965 |
|
2018
Q1 | $266K | Hold |
1,781
| – | – | ﹤0.01% | 1095 |
|
2017
Q4 | $266K | Buy |
1,781
+27
| +2% | +$4.03K | ﹤0.01% | 1095 |
|
2017
Q3 | $265K | Buy |
1,754
+99
| +6% | +$15K | ﹤0.01% | 1123 |
|
2017
Q2 | $180K | Hold |
1,655
| – | – | ﹤0.01% | 1231 |
|
2017
Q1 | $180K | Buy |
1,655
+658
| +66% | +$71.6K | ﹤0.01% | 1231 |
|
2016
Q4 | $72K | Sell |
997
-7
| -0.7% | -$506 | ﹤0.01% | 1491 |
|
2016
Q3 | $87K | Buy |
1,004
+304
| +43% | +$26.3K | ﹤0.01% | 1436 |
|
2016
Q2 | $60K | Buy |
700
+107
| +18% | +$9.17K | ﹤0.01% | 1510 |
|
2016
Q1 | $46K | Sell |
593
-158
| -21% | -$12.3K | ﹤0.01% | 1550 |
|
2015
Q4 | $94K | Hold |
751
| – | – | ﹤0.01% | 1379 |
|
2015
Q3 | $77K | Buy |
751
+47
| +7% | +$4.82K | ﹤0.01% | 1448 |
|
2015
Q2 | $85K | Sell |
704
-25,470
| -97% | -$3.08M | ﹤0.01% | 1463 |
|
2015
Q1 | $3.09M | Hold |
26,174
| – | – | 0.02% | 507 |
|
2014
Q4 | $3.11M | Buy |
26,174
+72
| +0.3% | +$8.55K | 0.02% | 484 |
|
2014
Q3 | $2.93M | Sell |
26,102
-165
| -0.6% | -$18.5K | 0.03% | 477 |
|
2014
Q2 | $2.49M | Sell |
26,267
-60
| -0.2% | -$5.68K | 0.02% | 514 |
|
2014
Q1 | $1.86M | Hold |
26,327
| – | – | 0.02% | 565 |
|
2013
Q4 | $1.96M | Buy |
26,327
+25,423
| +2,812% | +$1.89M | 0.02% | 539 |
|
2013
Q3 | $67K | Buy |
904
+230
| +34% | +$17K | ﹤0.01% | 1508 |
|
2013
Q2 | $53K | Buy |
+674
| New | +$53K | ﹤0.01% | 1511 |
|